Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8721638 | Diabetes & Metabolism | 2018 | 7 Pages |
Abstract
Gla-300 provides less fluctuating steady state pharmacodynamic profiles (i.e. lower within-day variability) and more evenly distributed pharmacokinetic profiles, compared with Deg-100 in a once-daily morning dosing regimen of 0.4Â U/kg/day.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
T.S. Bailey, J. Pettus, R. Roussel, W. Schmider, M. Maroccia, N. Nassr, O. Klein, G.B. Bolli, R. Dahmen,